Kadmon is a biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology, and genetic diseases.
|HQ||New York, US|
|Size (employees)||103 (est)+3%|
Gross profit (Q3, 2018)
Gross profit margin (Q3, 2018), %
Net income (Q3, 2018)
EBIT (Q3, 2018)
Market capitalization (14-Dec-2018)
Closing stock price (14-Dec-2018)
|USD||Q2, 2016||Q3, 2016||Q1, 2017||Q2, 2017||Q3, 2017||Q1, 2018||Q2, 2018||Q3, 2018|
Cash From Operating Activities
When was Kadmon founded?
Kadmon was founded in 2010.
Who are Kadmon key executives?
Kadmon's key executives are Harlan Waksal, Steven Gordon and John Ryan.
How many employees does Kadmon have?
Kadmon has 103 employees.
What is Kadmon revenue?
Latest Kadmon annual revenue is $12.3 m.
What is Kadmon revenue per employee?
Latest Kadmon revenue per employee is $119.1 k.
Who are Kadmon competitors?
Competitors of Kadmon include MyoKardia, Athersys and Otonomy.
Where is Kadmon headquarters?
Kadmon headquarters is located at 450 E 29th St, New York.
Where are Kadmon offices?
Kadmon has an office in New York.
How many offices does Kadmon have?
Kadmon has 1 office.